| News for nuclear medicine and molecular imaging professionals |  |
| |
|
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple
internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher.
The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may
be directed to SmartBrief at snmmi@smartbrief.com.
|
| Top Story
|  |  |
|
- Study finds decline in abnormal cardiac stress tests
The rate of abnormal stress-rest SPECT-MPI tests has declined from 40.9% in 1991 to 8.7% in 2009, according to a study published in the Journal of the American College of Cardiology. The researchers also observed a similar trend concerning ischemic results and moderately to severely abnormal findings. The study reviewed data on 39,515 patients at Cedars-Sinai Medical Center in Los Angeles. The results "may be reflecting a broader temporal change toward milder clinical presentations of coronary artery disease (CAD)," according to the researchers. They said the report "suggests a need to refine the future diagnostic workup of patients with suspected CAD." MedPage Today (free registration)
(3/5)
| Clinical News & Research
| | |
|
- Researchers, vendors work to improve imaging of obese patients
There are numerous challenges involved with molecular imaging of obese patients, including issues with radioisotope dosing and image acquisition and interpretation, according to Dr. Abdelhamid H. Elgazzar of Kuwait University. "It's crucial to take safety precautions and devise a strategy for preparation and interpretation of studies for this population," Elgazzar said. While researchers work to improve image quality, vendors are working to address logistical challenges with imaging cameras and tables that are more suited for such patients. MolecularImaging.net
(3/4)
| Industry Report
| | |
|
- Nordion: No decision on future plans
Nordion has reported reduced quarterly losses owing to greater income tax recovery. Nordion, which has retained advisers to consider future options, said, "No decision has been made to enter into any specific strategic transaction or any other strategic alternative at this time." Reuters
(3/5)
| News from the Field
| | |
|
| Health Policy
| | |
|
- White House to Congress: Exempt FDA user fees from sequester
The Obama administration urged Congress to allow the FDA to spend $41 billion in drugmaker user fees. The sequestration law limits the amount of fee-derived funds that the agency can spend, and experts warn that the agency will not be able to approve new drug and device applications quickly if the funds are subject to sequestration. Sequestration will slow progress toward cures and cost thousands of researchers their jobs, the White House warned. PharmaTimes (U.K.)
(3/5)
, The Philadelphia Inquirer
(2/28)
| Advancing Health Care
| | |
|
| From SNMMI
| | |
|
| SmartQuote
| | |
|
 | Every time you spend money, you're casting a vote for the kind of world you want."
--Anna Lappé,
American writer, speaker and activist
|
| |
| |
|
Read more at
SmartBrief.com |
|
|
|
| |
| |
| | Recent
SNMMI SmartBrief Issues:
- Tuesday, March 05, 2013
- Monday, March 04, 2013
- Friday, March 01, 2013
- Thursday, February 28, 2013
- Wednesday, February 27, 2013
| | | Lead Editor:
Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2013 SmartBrief, Inc.®
Legal Information |
|
